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ABSTRACT 
INTEGRIN INHIBITOR CYCLORGDN BLUNTS ENHANCED LPS-INDUCED LIVER INJURY 
CAUSED BY ETHANOL IN MICE 
Veronica L. Massey 
11/15/2012 
Background. Progression of alcoholic liver disease (ALD) is associated with an increase 
in fibrin extracellular matrix (ECM) and inflammation. Previous studies have shown that this 
accumulation of fibrin in ALD is mediated by impaired fibrinolysis. Additionally, it is known that 
fibrin(ogen) interacts with the av~3 integrin of endothelial cells. The purpose of this study was to 
test the hypothesis that hepatic inflammation caused by alcohol is mediated, at least in part, by 
activation of integrin av~3 by fibrin(ogen). To test this hypothesis, a study was designed to 
determine the effect of cycloRGDN, a peptide inhibitor of integrin av~3, in a mouse model of 
lipopolysaccharide (LPS)-induced inflammation enhanced by ethanol pre-exposure. Methods. 
Accordingly, male C57BLl6J mice were exposed to ethanol (6 g/kg i.g.) or isocaloriclisovolumetric 
maltose dextrin solution for 3 days and injected with lipopolysaccharide (LPS; 10 mg/kg i.p.) 24 
hours after the last dose of ethanol. Some animals received the av~3 integrin inhibitor 
(cycloRGDN; 3 mg/kg i.p.) 1 hour prior to LPS administration. Animals were sacrificed 8 or 24 
hours after LPS administration. Liver damage was assessed by plasma (AL T, AST) and 
histological indices of liver damage (hematoxylin and eosin; H&E) and inflammation 
(chloroacetate esterase; CAE). Results. Ethanol pre-exposure enhanced liver injury due to LPS, 
as indicated by a significant increase in plasma AL T levels. cycloRGDN significantly attenuated 
the increase in plasma AL T caused by ethanol pre-exposure. These results were supported by 
histological changes. Animals that received ethanol and LPS had both larger and more 
numerous necroinflammatory foci compared to animals that received LPS alone. The number 
v 
and severity of necroinflammatory foci was reduced by cycloRGDN compared to LPS + ethanol. 
Ethanol pre-exposure enhanced the increase in neutrophil migration caused by LPS, as 
determined by CAE staining. Animals administered cycloRGDN had fewer infiltrating neutrophils 
compared to those that received a combination of ethanol and LPS. Conclusions. These data 
suggest that cycloRGDN administration protects against liver injury caused by a combination of 
alcohol and LPS exposure. CycloRGDN also blunts ethanol-enhanced neutrophil infiltration 
caused by LPS in this model. Therefore, integrin av~3 may play an important role in enhanced 
hepatic inflammation and injury due to LPS after ethanol pre-exposure. 
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INTRODUCTION 
Alcoholic liver disease (ALD) affects more than 10 million Americans a year at a cost of more 
than $166 billion annually to treat the medical consequences of alcohol abuse(1). ALD is a 
spectrum of disease states that includes steatosis, steatohepatitis, and fibrosis and cirrhosis. 
Steatosis is the least severe stage of disease, characterized by fat accumulation in the liver. In 
some cases, continued alcohol consumption results in development of steatohepatitis, a disease 
state distinguished by chronic inflammation and the persistence of accumulated fat. The most 
severe stages of alcoholic liver disease include fibrosis and cirrhosis, which are characterized by 
collagen matrices and regenerative nodules, respectively. Despite the vast amount of money 
spent on treating alcoholic liver disease, therapeutic options are limited to palliative care, as no 
Food and Drug Administration (FDA)-approved therapy currently exists to halt or reverse disease 
progression. If a rational targeted therapy is to be developed, currently accepted mechanisms 
behind disease progression must be better understood and novel targets identified. 
The mechanisms involved in the various stages of alcohol-induced liver injury have been 
extensively investigated using animal models that recapitulate the specific stages of the disease 
(i.e., steatosis, inflammation and fibrosis). However, the mechanisms behind progression of ALD 
from earlier stages (i.e., steatosis) to later stages (i.e., steatohepatitis), remain unclear although 
critical to our understanding of how to blunt progression. 2-hit models of alcohol-induced liver 
injury can be used to study inflammatory injury due to alcohol. In such models, alcohol serves as 
a 'first hit' that sensitizes the liver to a 'second hit' such as lipopolysaccharide (LPS) resulting in 
organ injury. For example, the acute ethanol 2-hit model of alcohol-induced liver injury and 
inflammation is characterized by enhanced lipopolysaccharide (LPS)-induced liver injury and 
inflammation caused by alcohol pre-exposure (2). This acute alcohol exposure model has been 
used to show that fibrin deposition strongly correlates to enhanced LPS-induced liver injury and 
inflammation in mice. Furthermore, blocking fibrin accumulation protected against enhanced liver 
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injury and inflammation caused by alcohol in this model. Other studies have shown that fibrin 
accumulation is an early change during chronic alcohol exposure (Arteel et ai, unpublished data). 
These data implicate fibrin as an important player in enhanced inflammation and injury caused by 
acute alcohol exposure. Fibrin(ogen) is a structural component of the extracellular matrix (ECM) 
regulated by the coagulation cascade. Fibrin's role in inflammation has been highlighted by its 
ability to exert a myriad of inflammatory effects. For example, Qi and colleagues showed that 
fibrin induces IL-8 expression by vascular endothelial cells (3). Fibrin matrices also enhance 
migration of inflammatory cells in vitro, including IL-8 stimulated neutrophils (4). Whereas fibrin's 
pro-inflammatory effects are well documented, the mechanism by which this extracellular matrix 
component mediates these effects remains unclear. 
Fibrin matrices could mediate inflammatory effects either via their structural role as a 
component of the ECM or by acting as signaling molecules. Fibrin serves as a ligand of the 
integrin family of cell surface adhesion receptors, particularly the integrin ov133 (5). Integrins are 
heterodimeric receptors expressed on many cell types, including endothelial cells, inflammatory 
cells including macrophages and neutrophils, and platelets (6). Integrins are a diverse 
superfamily with at least 24 different heterodimers that are important in a variety of cell processes 
including proliferation (7), angiogenesis (8, 9), and inflammation (10). Upon interaction with 
extracellular components, such as fibrin, the 13 subunit of an integrin can undergo a rapid 
conformational change. This change in integrin structure allows for transfer of information across 
the plasma membrane by activation of intracellular signaling pathways. Adaptor proteins, such as 
integrin linked kinase (ILK), paxillin and focal adhesion kinase (FAK), are important mediators in 
signal transduction downstream of integrin activation and playa role in specifying which signaling 
cascades are activated within the cell (11-15). Owing to their myriad of effects on growth, 
angiogenesis and inflammation, integrin inhibitors have been investigated for therapeutic use. 
For example, small peptide inhibitors of integrins, including integrins 04131, 04137, and ov133 are 
currently in clinical trial for treatment of asthma, chronic obstructive pulmonary disease (16), and 
certain types of cancer (17). 
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The role of integrin av~3 in tumor angiogenesis and metastasis is well documented and 
stimulation of integrin av~3 also has been shown to contribute to inflammation (18). Integrin av~3 
is strongly expressed by endothelial cells (19) including those that line the hepatic sinusoids 
where fibrin accumulates after alcohol exposure. Moreover, integrin av~3 expression has been 
correlated temporally to fibrin deposition (20). Integrin av~3 binds fibrin(ogen) via an arginine-
glycine-aspartic acid (RGO) sequence on the fibrin molecule (5), allowing the interaction between 
fibrin and this integrin to be studied using small, commercially available peptide antagonists (21). 
The experiments described here were performed to test the hypothesis that hepatic 
inflammation caused by alcohol is mediated, at least in part, by activation of integrin av~3 by 
fibrin(ogen). The goal of this study was to determine the effect of a peptide inhibitor of integrin 
av~3, cycioRGON, in an acute ethanol 2-hit mouse model of hepatic inflammatory injury. 
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MATERIALS AND METHODS 
Animals and Treatments 
Eight week old male C57BU6J mice were purchased from the Jackson Laboratory (Bar 
Harbor, ME). Mice were housed in a pathogen-free barrier facility accredited by the Association 
for Assessment and Accreditation of Laboratory Animal Care, and procedures were approved by 
the University of Louisville's Institutional Animal Care and Use Committee. Food and tap water 
were provided ad libitum. Mice received ethanol (6 g/kg i.g.) or isocaloric/isovolumetric maltose-
dextrin solution for 3 days and were injected with LPS (E. coli, serotype 055:B5; Sigma, St. Louis, 
MO; 10 mg/kg i. p.) 24 hours after the last dose of ethanol (2) (Figure 1) . The av133 integrin 
inhibitor cycioRGON (Enzo Life Sciences, Plymouth Meeting, PA; 3 mg/kg i.p.) or vehicle (PBS) 
was injected 1 hour prior to LPS administration. Animals were anesthetized with 
ketamine/xylazine (100/15 mg/kg, i.m.) 8 or 24 hours after LPS administration. Blood was 
collected from the vena cava just prior to sacrifice by exsanguination and citrated plasma was 
stored at -80DC for further analysis. Portions of liver tissue were snap-frozen in liquid nitrogen, 
frozen-fixed in OCT-Compound (Sakura Finetek, Torrance, CA), or were fixed in 10% neutral 
buffered formalin for subsequent sectioning and mounting on microscope slides. 
Clinical Chemistry and Pathologic Evaluation 
Levels of alanine aminotransferase (AL T) and aspartate aminotransferase (AST) were 
determined spectrophotometrically using standard kits (Thermotrace, Melbourne, Australia). 
Plasma hyaluronic acid (HA) was quantitated using an ELISA kit (Corgenix, Broomfield, CO). 
Formalin fixed, paraffin embedded sections were cut at 5 IJm and mounted on glass slides. 
Sections were deparaffinized and stained with hematoxylin and eosin (H&E). Chloroacetate 






Figure 1: Acute ethanol 2-hit model of liver injury. 
Mice received a dose of ethanol (6 g/kg i.g .) or isocaloric/isovolumetric maltose-
dextrin solution for 3 d and were injected with LPS (10 mg/kg i.p.) or vehicle 
(saline) 24 hours after the last dose of ethanol or control diet. The avj33 integrin 
inhibitor cycioRGON (3 mg/kg i. p.) or vehicle (PBS) was injected 1 hour prior to 
LPS administration . 
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esterase kit (Sigma, St. Louis, MO) on paraffin embedded samples. The extent of CAE staining 
was quantified by blinded counting of CAE-positive neutrophils per 1000 hepatocytes (22). CAE-
positive cells counted during quantification were characterized by light pink (i.e. CAE-positive) 
staining and bi-Iobed nuclear morphology. 
RNA Isolation and Quantitative Reverse-Transcriptase Polymerase Chain Reaction 
The hepatic mRNA expression of select genes was detected by quantitative reverse-
transcriptase polymerase chain reaction (rt-PCR), which is routine for this group (2, 23-25). PCR 
primers and probes for TN Fa, PAI-1, IL-6, IL-10 and ~-actin were designed using Primer 3 
(Whitehead Institute for Biomedical Research, Cambridge, MA). Primers and probes for CD31, 
integrin av, integrin ~3, C-fos, C-myc, and SOCS3 were bought from Applied Biosystems as kits 
(Foster City, CA). All primers were designed to cross introns to ensure that only cDNA and not 
genomic DNA was amplified. Total RNA was extracted from liver tissue by a guanidinium 
thiocyanate-based method (RNA STAT 60 Tel-Test, Ambion, Austin, TX). RNA concentrations 
were determined spectrophotometrically and 1 IJg of total RNA was reverse transcribed using a 
kit (Quanta Biosciences, Gaithersburg, MD). PerfeCta qPCR Fast Mix (Quanta Biosciences, 
Gaithersburg, MD) was used to prepare the PCR reaction mixture. This 2X mixture is optimized 
for TaqMan reactions and contains MgCI2 , dNTPs, and AccuFast Taq DNA Polymerase. 
Amplification reactions were carried out using the ABI StepOne Plus machine and software 
(Quanta Biosciences, Gaithersburg, MD) with initial holding stage (95°C for 30 seconds) and 50 
cycles of a 2-step PCR (95°C for 30 seconds, 60°C for 20 seconds). Fluorescent intensity of 
each sample was measured at each cycle to monitor amplification of the target gene. The 
comparative CT method was used to determine fold changes in mRNA expression compared to 
an endogenous reference gene (~-actin). This method determines the amount of target gene, 
normalized to an endogenous reference and relative to a calibrator (2-LILICt). 
Immunostaining 
6 
For immunofluorescent detection of the platelet endothelial cell adhesion molecule 
(CD31), formalin-fixed, paraffin-embedded sections (5IJm) were deparaffinized and then 
rehydrated with graded ethanol solutions. Slides were incubated in primary antibody for CD31 
(Abcam, Cambridge, MA). A secondary antibody, goat anti-rat Alexa 488-lgG was used 
(Invitrogen, Carlsbad, CA). Samples were mounted and counterstained with Vectashield with 
DAPI (Vector laboratories, Burlingame, CA). Immunofluorescent detection of fibrin deposition 
was performed as described in (22). Briefly, frozen liver sections (6 IJm thick) were fixed in 10% 
buffered formalin containing 2% acetic acid to solubilize all but cross-linked fibrin. Sections were 
blocked with PBS containing 10% horse serum before an overnight incubation at 4°C with affinity 
purified rabbit anti-human fibrionogen IgG (Dako North America, Inc. Carpinteria, CA) diluted in 
blocking solution. Donkey anti-rabbit antibody conjugated to Alexa 488 (Invitrogen, Carlsbad, 
CA) was used as secondary antibody. Tissue was counterstained with Hoechst. Fluorescence 
for Alexa 488 and Hoechst was detected at excitation and emission wavelengths of 490 nm and 
520 nm, and 350 nm and 460 nm, respectively. Immunofluorescence was visualized using a 
Nikon Eclipse E600 microscope (Nikon Corporation, Tokyo, Japan) and Metamorph software. 
Immunoblots 
All buffers used for protein extraction contained protease, tyrosine phosphatase, and 
serine-threonine phosphate inhibitor cocktails (Sigma, St. louis, MO). Liver samples were 
homogenized in CHAPs buffer (50 mM Tris/CI, pH 7.4,5 mM EDTA, 5 mM EGTA, 1% (w/v) 
PMSF). Homogenized samples were loaded onto SDS-polyacrylamide gels containing 10% (w/v) 
acrylamide, followed by electrophoresis and Western blotting onto nitrocellulose membranes 
(Hybond P, GE Healthcare, Piscataway, NJ). Primary antibodies against phosphorylated and 
total extracellular-signal-regulated kinases 1 and 2 (ERK1/2), c-Jun N-terminal kinases 1 and 2 
(JNK1/2), signal tranducer and activator of transcription 3 (STAT3), focal adhesion kinase (FAK), 
and paxillin (Cell Signaling Technology, Beverly, MA) were used. Bands were visualized using an 
ECl kit (Pierce, Rockford, Il) and Hyperfilm (GE Healthcare, Piscataway, NJ). Densitometric 
analysiS was performed using UN-SCAN-IT Gel (Silk Scientific, Orem, UT) software. 
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Statistical Analyses 
Results are reported as means ± standard error mean (SEM; n = 4-7). ANOVA with 
Bonferroni's post-hoc test (for parametric data) or Mann-Whitney Rank Sum test (for 
non parametric data) was used for the determination of statistical significance among treatment 




Hepatic integrin expression and fibrin deposition. 
The purpose of these studies was to investigate the role of integrins in mediating the pro-
inflammatory effects of fibrin in the pre-fibrotic phase of alcoholic liver disease (ALD). Therefore, 
it was necessary to verify that the effects of cycloRGDN administration were not due to changes 
in hepatic integrin expression or fibrin accumulation in the liver. To determine effects on integrin 
expression, quantitative rt-PCR was performed for the av and ~3 integrin subunits. LPS alone did 
not significantly affect hepatic mRNA levels of either the av or ~3 integrin subunits (Figure 2). 
The combination of ethanol and LPS significantly increased levels of integrin av and ~3 integrin 
subunit mRNA expression (by -2-fold and -1.4 fold, respectively) compared to LPS alone and 
naIve controls, respectively. CycloRGDN did not have a significant effect on the mRNA 
expression of either integrin subunit. 
The effect of LPS and ethanol on hepatic accumulation of fibrin was determined by 
immunofluorescence. LPS robustly increased hepatic fibrin deposition 8 hours after LPS 
administration (Figure 3). Fibrin deposition was primarily located in the hepatic sinusoidal space. 
As has been observed previously (2), ethanol pre-exposure enhanced the accumulation of fibrin 
caused by LPS. CycloRGDN administration did not alter the effect of LPS or ethanol on fibrin 
accumulation in mouse liver. 
CycioRGOfV protects against enhanced liver injury and neutrophil infiltration. 
LPS administration resulted in inflammatory focie in mouse liver compared to animals 
(Figure 4). As has been observed previously, ethanol significantly increased the detrimental 
effect of LPS as evidenced by necroinflammatory focie in the hepatic tissue of animals that 
received the combination of ethanol and LPS. Administration of cycloRGDN blunted the effect of 
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Figure 2 
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Figure 2: Effect of cycloRGDfV on integrin mRNA expression. 
Male C57BLl6J mice were given ethanol or isocaloric, isovolumetric control diet 3 
days and injected with LPS or saline vehicle either 8 or 24 h after the last dose of 
ethanol, with some animals receiving cycloRGDN 1 h prior to LPS as described 
in Methods. Hepatic mRNA expression of the av and ~3 integrin subunits were 
determined by real time RT-PCR. Data are means ± SEM (N=4-6). ap<O.05 




Figure 3: Effect of cyc/oRGDfV on hepatic fibrin deposition. 
Animals were treated as described in Methods. Representative 
photomicrographs (400x) of immunofluorescent detection of fibrin deposition at 
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Figure 4: Effeet of eye/oRGDfV on liver injury. 
a,b 24 h 
c 
+ + + 
+ + 
+ 
Representative photomicrographs (200x; 400x insets) of hematoxylin & eosin 
staining are shown (top panel). Inflammatory foci were seen in the liver of 
animals that received LPS and a combination of ethanol , LPS, and cycloRGDN. 
Necroinflammtory foci were observed in animals that received ethanol and LPS 
without the integrin inhibitor. The plasma AL T and AST levels were analyzed by 
spectrophotometric analysis (lower panels) . Data are means ± SEM (n = 4-6) . 
ap<O .05 compared to MD controls ; bp<O.05 compared to LPS alone; cp<O.05 
compared to LPS + ethanol. 
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ethanol under these conditions and livers resembled those of animals exposed to LPS alone. 
Administration of LPS alone significantly increased the number of infiltrating neutrophils 24 hours 
after LPS administration (Figure 5). Ethanol pre-exposure enhanced the increase in neutrophil 
migration caused by LPS by -2 fold. CycioRGDN blunted this effect of ethanol pre-exposure, 
with the average number of infiltrating neutrophils in this group similar to those treated with LPS 
alone. Ethanol pre-exposure enhanced liver injury due to LPS 24 hours after LPS administration, 
as indicated by a significant increase in plasma AL T levels (Figure 4, bottom left). CycloRGDN 
protected against enhanced levels of circulating transaminases, significantly blunting serum 
levels of AL T and AST. There were no significant differences in serum levels of AL Tor AST or 
gross liver morphology due to alcohol pre-exposure or cycioRGDN 8 hours after LPS (Figure 4, 
bottom right) (2). 
CycloRGDfV did not affect mRNA expression of cell adhesion and inflammatory genes. 
In order to further evaluate the effect of cycioRGDN on inflammation in this model, hepatic 
mRNA expression of a panel of inflammatory cytokines and cell adhesion proteins was 
determined (Table 1). The pro-inflammatory cytokines TNFa and IL-6 as well as the anti-
inflammatory cytokine IL-10 were significantly increased in all groups compared to maltose-
dextrin fed controls by -50-, 150-, and 25-fold, respectively; cycioRGDN did not affect the 
expression of TN Fa, IL-6, or IL-10 compared to animals that received LPS or a combination of 
LPS and ethanol. PAI-1 expression was significantly increased in all groups compared to 
controls. Expression of intracellular adhesion molecule-1 (ICAM-1) was significantly increased in 
all groups compared to controls. The hepatic mRNA expression of the cell surface receptor 
CD31 was significantly decreased by LPS administration compared to saline administration. 
Ethanol preexposure and cycioRGDN did not significantly affect mRNA expression of CD31 
compared to LPS alone. Integrins affect intracellular signaling via interaction with adaptor 
proteins and kinases, including the integrin-linked kinase (ILK). Hepatic mRNA expression of the 
integrin linked kinase (ILK) was significantly decreased in the groups that received LPS alone or 
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Figure 5: Effect of cycloRGDfV on neutrophil infiltration. 
Representative photomicrographs (400x) of chloroacetate-esterase staining are 
shown (top panel). Number of neutrophils were quantitated as described in 
Methods (bottom panel) . Data are means ± SEM (n = 4-6) . ap<O.05 compared to 
MD controls; bp<O.05 compared to LPS alone; cp<O.05 compared to LPS + 
ethanol. 
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Table 1: Hepatic mRNA Expression. a indicates p>O.S compared to control; b 
indicates p>O.S compared to LPS 
EtOH + LPS + 
MD Control MD + LPS EtOH + LPS RGDfV 
8 hours 
TNFalpha 1.0±O.37 42.9±8.Sa 4S.1±S.3a 76.9±21.9a 
IL-6 1.0±O.O8 131±1S.1a 138±23.2a 177±38.7a 
IL-10 1.0±O.32 23.8±2.1a 26.37±3.8a 26.7±S.Sa 
PAI-1 1.0±O.43 1443±278a 183S±210a 1327±296a 
ICAM 1.0±O.24 10.6±1.8a 11.3±1.2a 9.S±3.Sa 
CD31 1.0±O.32 O.26±O.04a O.40±O.06a O.40±O.07a 
ILK 1.0±O.O6 O.3S±O.04a O.S6±O.08a O.69±O.1S 
c-Fos 1.0±O.1S 1.2±O.16 1.11±O.17 2.2±1.02 
c-Myc 1.0±O.19 2.3±O.3S 1.9±O.2S 1.7±O.24 
SOCS3 1.0±O.23 4.0±O.S8 8.4±1.4a,b S.4±O.94a,c 
24 hours 
c-Fos 1.0±O.O3 O.7S±O.14 1.6±O.14a,b 1.1±O.17c 
c-Myc 1.0±O.21 O.97±.21 O.89±.O97 1.3±O.14 
SOCS3 1.0±O.23 1.71±O.60 2.6±O.80 1.2±O.1S 
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ethanol and LPS were protected from this decrease in ILK expression. 
Endothelial cell dysfunction 
Platelet endothelial cell adhesion molecule (CD31) is a cell surface receptor expressed 
on endothelial cells which may be important in neutrophil migration as well as integrin activation 
(26). The expression of CD31 was decreased by more than half in all groups compared to 
controls (Table1). However, immunofluorescent staining for CD31 was increased by LPS, and 
this increase was blunted by ethanol pre-exposure (Figure 6). CD31 expression in animals 
administered cycloRGDN was greater than that in animals that received a combination of ethanol 
and LPS without the drug. LPS exposure significantly elevated levels of circulating hyaluronic 
acid (HA) (Figure 7). Neither ethanol preexposure nor cycloRGDN administration significantly 
affected levels of HA compared to animals that received LPS alone. 
Phosphorylation of signaling molecules downstream of integrin activation 
Activation of integrins by extracellular ligands causes a rapid conformational change in 
the cytosolic domain of the integrin's beta subunit allowing association of adaptor proteins and 
activation of subsequent signaling cascades, including ERK and JNK (27). The phosphorylation 
status of ERK1/2 and JNK1/2 were determined by Western blot (Figure 8). Phosphorylation of 
ERK1/2 was significantly decreased in all groups compared to controls. Levels of phospho-
JNK1/2 were not significantly affected by any treatment. To explore further the effect of blocking 
integrin signaling, the phosphorylation status of the adaptor proteins focal adhesion kinase (FAK) 
and paxillin was also determined. Phosphorylation of FAK was significantly decreased in all 
experimental groups compared to controls (Figure 8). However, the phorphorylation status of 
paxillin was not significantly affected in any of the treatment groups. 
Effect of cycloRGDfV on STAT3 phosphorylation and STAT3 regulated genes 





Figure 6: Effect of eye/oRGDfV on CD31 expression. 
Hepatic CD31 expression was determined by immunofluorescent detection as 
described in Methods. Representative photomicrographs (400x) of the 8 h time 
























Plasma levels of HA were determined for the 8 hour time point as described in 
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Figure 8: Phosphorylation of signaling kinases and adaptor proteins. 
Immunoblots were performed as described in Methods. Representative 
immunoblots for phosphorylated and total ERK, JNK, FAK, paxillin , and STAT3 
for the 8 h time point are shown (top panel). Phosphorylated protein levels were 
normalized to levels of total protein and quantified by densitometry. Data are 
means ± SEM (n = 4-6). ap<O.05 compared to MD controls. 
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JAKISTAT signaling (i.e. IL-6; Table 1), expression of JAKISTAT responsive genes was 
differentially affected by ethanol preexposure and cycloRGDN. Eight hours after LPS 
administration, no significant changes were seen in mRNA expression of c-Myc or c-Fos, 
however suppressor of cytokine signaling 3 (SOCS3) mRNA expression was significantly 
increased in animals pre-exposed to ethanol compared to those administered LPS alone (Table 
1). CycloRGDN administration blunted the increase in expression of SOCS3 caused by ethanol 
preexposure followed by LPS. Whereas mRNA expression of SOCS3 and c-Myc were similar 
across all groups 24 hours after LPS, expression of c-Fos was significantly increased by ethanol 
pre-exposure compared to LPS alone. CycloRGDN attenuated this increase in c-Fos caused by 
ethanol and LPS. The ratio of phosphorylated signal transducer and activator of transcription 3 
(STAT3) to total STAT3 was significantly increased by LPS administration compared to maltose-
dextrin fed controls (Figure 8). Ethanol preexposure blunted this increase in STAT3 
phosphorylation; cycloRGDN had no effect on phosphorylation of ST AT3 compared to controls or 
ethanol preexposed animals. 
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DISCUSSION 
Previous studies from using this 2-hit model of liver injury have shown that hepatic fibrin 
accumulation is correlated to liver injury and inflammation (2). Furthermore, enhanced LPS-
induced liver injury and inflammation caused by alcohol was prevented by blocking fibrin 
accumulation. Such studies suggested that fibrin plays a pro-inflammatory role in alcoholic liver 
injury, however the mechanism by which fibrin mediates these effects remain unclear. The 
experiments described here were performed to test the hypothesis that fibrin mediates pro-
inflammatory effects in the liver via interaction with integrins, specifically integrin av~3, in a 2-hit 
model of acute alcohol exposure. 
While nearly all individuals who drink alcohol develop some degree of steatosis, only a 
small fraction of alcoholics ever progress to steatohepatitis, a disease state characterized by 
persistent inflammation and continued fat accumulation. One explanation for this phenomenon is 
the 2-hit hypothesis proposed by Day and James (28). The 2-hit hypothesis suggests that ethanol 
exposure is not sufficient for alcoholic liver disease, but rather that a second hit is required in 
order for later stages of disease to develop. Thus, 2-hit models of liver injury, where ethanol 
serves as the 'first hit' that sensitizes the liver to a 'second hit' such as LPS are commonly used 
to study alcoholic liver disease. The acute 2-hit model (Figure 1) of alcohol exposure was chosen 
for this study because the response to LPS with and without alcohol preexposure appears similar 
mechanistically to certain aspects of alcohol-induced liver injury, specifically the inflammatory 
phase of steatohepatitis. Indeed, although ethanol alone causes no gross morphological 
changes in this model, it nevertheless robustly enhances liver injury caused by LPS (2). 
The experiments described in this thesis were designed to study the role of the integrin 
av~3 in enhanced LPS-induced liver injury after acute alcohol exposure. The integrin av~3 was 
specifically chosen for this study because of its proximity to fibrin ECM molecules and ability to 
bind RGD-containing ECM components including fibrin. Indeed, integrin av~3 is expressed by 
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sinusoidal endothelial cells which line the sinusoids where fibrin accumulates in the acute 2-hit 
model of alcohol exposure used for this study. Additionally, others have shown the integrin av133 
binds fibrin (5). The interaction between RGD-containing ECM components, such as fibrin, and 
the integrin av133 can be studied using commercially available peptide antagonists such as 
cycloRGDN. CycloRGDN is a small cyclic peptide that binds the av133 integrin, preventing the 
integrin's interaction with other molecules. CycloRGDN was chosen for use in this study 
because of its relative specificity for integrin avl33. 
As expected, LPS administration significantly increased fibrin deposition (Figure 3), liver 
damage (Figure 4) and liver inflammation (Figure 5), all of which were enhanced by alcohol 
preexposure. Animals that received cycloRGDN were protected against enhanced liver injury 
and inflammation, but had fibrin deposition similar to animals that received only ethanol and LPS. 
These observations support our hypothesis and show that the protection conferred by 
cycloRGDN was independent of the magnitude of fibrin deposition. Protection was also 
independent of integrin expression (Figure 2), suggesting that the protective mechanism(s) at 
work in this model are 'downstream' of the ligand and receptor required for integrin activation, per 
se. 
Dysregulated immune response after alcohol exposure is known to contribute to the 
pathogenesis of ALD. Indeed, alcohol exposure can cause changes in the expression of 
inflammatory mediators favoring a pro-inflammatory profile that allows for normal tissue damage. 
For example, alcohol increases circulating levels of endotoxin (29) and sensitizes Kupffer cells, 
the resident macrophages of the liver, to stimulation by LPS (30). Moreover, sensitization of 
Kupffer cells by ethanol can result in enhanced release of pro-inflammatory mediators including 
TNFa (31). The release of TN Fa can result in recruitment and activation of other cells of the 
innate immune system, promoting necrotic cell death, such as that observed in animals that 
received a combination of ethanol and LPS in this study. Indeed mRNA expression of TN Fa, a 
pro-inflammatory cytokine released from activated Kupffer cells, was significantly increased by 
more than 40-fold in all groups compared to controls. Additionally, neutrophil count correlated to 
severity of liver injury with alcohol preexposure enhancing both injury and neutrophil count. 
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CycioRGON attenuated these detrimental effects of alcohol preexposure. These results suggest 
that the integrin antagonist may protect against liver injury by blunting the enhanced LPS-induced 
inflammatory response that occurs after ethanol preexposure. 
One mechanism by which cycioRGON may protect against inflammatory injury is by 
attenuating the increase in inflammatory mediators caused by alcohol preexposure. Indeed, 
protecting against increased levels of inflammatory mediators can protect against hepatic injury 
after alcohol exposure. However, cycioRGON did not differentially affect hepatic levels of the 
proinflammatory mediators TNF-a, IL-6, PAI-1 or the antiinflammatory cytokine IL-10. In fact, all 
groups had increased hepatic mRNA expression of TNF-a, IL-6, PAI-1, and IL-10 compared to 
controls (Table 1). These results demonstrate that the protective effects of cycioRGON were 
independent of changes in the mRNA expression of inflammatory mediators investigated in this 
study. 
Protection against enhanced inflammation in this model was indicated by Significantly 
fewer neutrophils in the liver tissue of animals that received cycioRGON in addition to ethanol 
and LPS compared to those that received the combination of ethanol and LPS without the integrin 
antagonist. Infiltration of neutrophils and other inflammatory cells into tissue is mediated by cell-
surface receptors. For example, ICAM-1, a cell surface adhesion receptor expressed by 
endothelial cells, interacts with neutrophil-specific receptors to allow for neutrophil chemotaxis. 
The mRNA expression of ICAM-1 was Significantly increased in all groups compared to controls 
and was not differentially affected by cycioRGON administration. C031, also known as platelet-
endothelial cell adhesion factor (PECAM), is a cell surface receptor expressed by sinusoidal 
endothelial cells (SECSs) and neutrophils (32) which has been linked to integrin activation (33). 
C031 receptors expressed on SECs can facilitate neutrophil transmigration via homophilic 
interactions with C031 receptors on immune cells such as neutrophils (12, 34). The mRNA 
expression of C031 was significantly decreased in all groups compared to controls. In contrast, 
protein expression of C031 in hepatic tissue was increased by LPS administration (Figure 6). 
Ethanol preexposure caused a robust decrease in C031 expression compared to LPS alone. 
This decrease in C031 expression caused by ethanol preexposure suggests that the enhanced 
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neutrophil migration caused by ethanol after an inflammatory stimulus was not a result of 
increased CD31-mediated neutrophil migration. CycloRGDN increased CD31 expression 
compared to ethanol + LPS. ConSidering the proinflammatory role of CD31 in neutrophil 
migration, increased CD31 expression caused by cycloRGDN administration would be expected 
to correlate with increased neutrophil migration into tissue, the opposite of what was observed in 
this study. In fact, cycloRGDN attenuated the increase in neutrophil migration caused by ethanol 
preexposure (Figure 5). Recent studies have shown that CD31 can facilitate neutrophil migration 
via heterophilic interactions with other cell surface receptors, including integrin av~3 (33) (Figure 
9, top panel). Indeed, blocking heterophilic interactions between CD31 and integrins can prevent 
neutrophil migration mediated by these interactions. In this study, the integrin antagonist 
cycloRGDN was used to block ECM-integrin av~3 interactions. However, cycloRGDN may have 
additionally blocked CD31-integrin avj33 interactions, preventing neutrophil migration mediated by 
such heterophilic interactions (Figure 9, bottom panel). This mechanism could explain the 
decrease in neutrophils in the liver tissue due to cycloRGDN despite increased hepatic CD31 
expression in these animals. 
CD31 also has potent anti-inflammatory roles; its expression has been shown to be 
protective against LPS-induced endotoxemia (35, 36). It comprises the majority of intracellular 
junctions of endothelial cells (37) and can mediate anti-inflammatory effects by maintaining 
vascular integrity (26). Additionally, increased CD31 expression on SECs indicates 
angiogenesis, which is important for recovery after liver injury. In this study, hepatic expression 
of CD31 was decreased by ethanol exposure and rescued by cycloRGDN administration. 
Reduction in CD31 expression in ethanol preexposed mice may indicate reduced vascular 
integrity and/or angiogenesis, two factors necessary for restoration of damaged hepatic tissue. 
CycloRGDN rescued CD31 expression. Thus, enhanced liver injury caused by alcohol exposure 
in this model may be due, at least in part, to an inability to recover after inflammatory insult. 
Furthermore, protection conferred by cycloRGDN may be a result of increased vascular integrity 
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Figure 9. Heterodimeric interactions of CD31 with integrin aVf33. CD31 
expressed on neutrophils has been shown to interact with the integrin av133 
expressed on endothelial cells. Interaction between CD31 and integrin av133 
allows for transmigration of neutrophils into tissue. One mechanism by which 
cycloRGDN may attenuate neutrophil migration into liver tissue is by blocking 
heterodimeric intearctions between CD31 and integrin avl33. 
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Previously published data using this model of alcohol exposure showed that increased 
activation of ERK1/2 4 h after LPS administration occurs downstream of TNFa and mediates 
increased PAI-1 expression and subsequent fibrin accumulation in the liver (2). Interestingly, 
integrin activation can also activate ERK signaling via changes in the phosphorylation status of 
various adaptor proteins (11). Whereas TNFa and PAI-1 mRNA expression were still significantly 
increased 8 hours after LPS administration in this study (Table 1), ERK1/2 phosphorylation was 
reduced in all groups compared to controls at this time point (Figure 8). Because activation of 
ERK1/2 can occur downstream of adaptor proteins that associate with the cytosolic domains of 
activated integrins, the phosphorylation status of FAK was determined. FAK is an integrin-linked 
adaptor protein that can contribute to activation of ERK signaling downstream of integrin 
activation (12). Phosphorylation of FAK was significantly decreased in all groups compared to 
controls; however neither ethanol preexposure nor cycloRGDN administration had additional 
effects on FAK phosphorylation (Fig. 8). Decreased FAK phosphorylation could account for the 
decrease in ERK1/2 signaling seen in our model, but not for the protective effects of cycloRGDN. 
Reduced FAK phosphorylation may also account for the decrease in phosphorylation of JNK 
which occurs downstream of FAK activation (27). However, changes in the phosphorylation 
status of these adaptor proteins and kinases cannot account for the protective effects of 
cycloRGDN in this model. 
Previous studies from this group have suggested a possibility for cross-talk between IL-6 
receptor signaling and integrin signaling via ST AT3 (Figure 10). JAK-ST AT Signaling pathways 
are activated by a myriad of extracellular signaling molecules, including IL-6. The JAK-STAT 
pathway has also been shown to be activated by other integrins (38). Upon binding of IL-6 to the 
IL-6 receptor (IL-6R), JAK undergoes autophosphorylation, allowing for the binding of and 
subsequent phosphorylation of STAT3. Although hepatic IL-6 mRNA expression was significantly 
increased in all groups, STAT3 phosphorylation was not Significantly affected by LPS, ethanol, or 
cycloRGDN compared to controls. The mRNA expression of the ST AT3-responsive genes c-
Fos, c-Myc, and SOCS3 was also determined. HepatiC c-Fos expression was significantly 











./ ~ Transcription t,. .... 
~ 
Colos 1 ( SOCS3 ][ e-mye 
Figure 10. Intracellular signaling downstream of integrin activation. Ethanol 
enhances increased fibrin deposition due to LPS. Fibrin is associated with pro-
inflammatory effects, possibly by activating integrins via its RGD sequence. 
Integrin activation triggers a myriad of intracellular signaling events including the 
phosphorylation of adaptor proteins (e.g . FAK, and paxillin) . Adaptor proteins 
facilitate activation of signaling cascades including MAPK and JNK and possibly 
crosstalk with IL-6 signaling via STAT3 activation. 
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mediate LPS-induced liver injury by increasing hepatic levels of proinflammatory chemokines (i.e. 
MIP-1a and MCP-1) (39). Therefore, blocking enhanced c-Fos expression could provide 
protection in this model. SOCS3 expression was differentially affected by ethanol pre-exposure 
and cycioRGON with integrin inhibition protecting against enhanced mRNA expression of SOCS3 
due to ethanol preexposure. 
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SUMMARY AND CONCLUSIONS 
STRENGTHS OF THIS WORK 
This work has many strengths. First, it identifies a new player, integrin avl33, in alcoholic 
liver disease. Currently, no FDA approved therapy exists to halt or reverse alcoholic liver 
disease. In order for new therapies to be developed, new key players must be identified as 
potential therapeutic targets. This work suggests that integrin inhibitors, some of which have 
already been studied in clinical trials for asthma and chronic obstructive pulmonary disease (16) 
as well as cancer therapies (17), may also be beneficial in treating ALD. More specifically, 
inhibitors of the integrin av133may be particularly useful in the inflammatory phases of liver injury 
such as steatohepatitis. 
All the work described here was performed in the whole animal. Use of the whole animal 
is particularly important when studying diseases that involve multiple organs, such as ALD. 
Indeed, although in vitro studies using single cell culture or co-culture are useful, whole animals 
experiments allow better translation to the human disease. Additionally, this study used a specific 
peptide inhibitor of integrin avl33, cycloRGDN. The use of a pharmacological inhibitor provides 
advantages over a whole mouse deletion of the avl3 integrin. Whole mouse deletions can result 
in non-specific effects due to compensatory mechanisms that are selected for early in 
development. Deletion of the 133 integrin subunit is highly lethal, and while some animals do 
survive to adulthood, the adult population of this strain of mouse may have compensatory 
mechanisms at work. 
For these studies, an acute model of alcohol-induced liver injury was used. While no 
model fully recapitulates the human disease, this model does provide a number of advantages 
over other alcohol feeding models. For example, in this model, the experimenter can control how 
much and when the animals ingest ethanol to ensure all animals receive similar concentrations of 
ethanol and reach similar states of inebriation. 
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CAVEATS AND WEAKNESSES 
The main purpose of this work was to investigate the role of integrin av(33 in a model of 
enhanced LPS-induced liver injury caused by alcohol. In order to study the effects of inhibiting 
integrin av(33, a commercially available peptide inhibitor, cycloRGDN, was used. While use of 
this inhibitor conveyed some advantages to this study, cycloRGDN may interact with other 
integrins that recognize RGD sequences. Furthermore, a variety of integrins recognize RGD 
sequences that could also interact with the RGD sequences of fibrin. Therefore, we cannot 
conclusively state that the specific interaction between av(33 and fibrin is the mechanism at work 
under these conditions. This study also did not offer insight into which cells are being primarily 
affected by cycloRGDN administration. Nearly all cells express a number of different integrin 
heterodimers and a single integrin can be expressed by a variety of cell types, for instance the 
integrin of primary interest in this study, av(33, is known to be expressed on SECS, Kupffer cells, 
neutrophils, and platelets. Additional studies would be required to examine more specifically the 
ECM-integrin interactions that are key to protection in this model. 
This study was conducted in an acute alcohol exposure model that enhances liver injury 
due to LPS. While this model has advantages (see Strengths), it does not fully recapitulate 
alcohol exposure in humans. This model requires forced feeding of alcohol to overcome rodents' 
natural aversion to ethanol, which prevents them from voluntarily consuming enough toxin to 
cause liver damage. Although this acute model of exposure has advantages, most liver damage 
is associated with chronic alcohol exposure. Therefore, effects found in this model do not 
necessarily recapitulate the chronic disease. However, recent studies suggest that a critical 
component of ALD may be 'acute on chronic' drinking behavior in which chronic alcoholics binge 
periodically. Additionally, acute models have proven to be a useful screening to complement 
chronic studies. Indeed, there is great mechanistic overlap of protective agents used in both 
acute and chronic models and, to date, there have been no 'false positives' observed when 
studying protective agents in acute models of alcohol exposure (40-42). This model recapitulates 
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the inflammatory aspects of the pre-fibrotic stages of alcoholic liver disease, mainly chronic 
inflammation. While the mechanisms involved in various stages of alcohol-induced liver injury 
have been extensively investigated, the mechanism behind progression from earlier stages of 
ALD (i.e. steatosis) to later stages, such as steatohepatitis, remain unclear. Accordingly, a 
major goal of this work was to identify key players in earlier, highly reversible stages of the 
disease with an emphasis on the inflammatory response characteristic of steatohepatitis and is 
the justification for using the model for this study. 
FUTURE DIRECTIONS 
The future directions described here are to address the issues discussed in Caveats and 
Weaknesses and the questions that remain unanswered with regard to the role of integrins in 
alcohol-induced organ injury. The purpose of the experiments described herein would be to build 
on the theme of this thesis, but are not necessary to complete this project. 
Role of integrins in animal models of chronic alcohol exposure. 
This study provides compelling evidence indicating that blocking integrin activation protects 
against enhanced LPS-induced liver injury caused by acute alcohol exposure, However, the role 
of ~3-containing integrins after chronic alcohol exposure remains unknown. While the model used 
in this study recapitulates the chronic inflammation characteristic of pre-fibrotic stages of liver 
injury, steatosis does not persist in this model. Acute models of alcohol exposure are convenient 
and allow for more precise control over timing and extent of inebriation, however chronic models 
of alcohol exposure better recapitulate the human condition. The role of ~3-containing integrins 
in alcohol-induced organ injury could be investigated further using a chronic model of alcohol 
exposure and ~3-1- mice. A whole animal knockout would be advantageous in a chronic model of 
alcohol exposure in order to ensure that activity of ~ subunit-containing integrins is inhibited 
throughout the duration of the study. 
Do integrins mediate susceptibility to injury in the alcoholic lung? 
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Integrins have also been shown to playa role in enhanced susceptibility to lung injury 
caused by alcohol exposure. Alcohol is known to sensitize to acute lung injury (43, 44). These 
effects may be due to a myriad of changes that occur after ethanol exposure and are similar to 
changes seen in alcohol-induced liver injury and include altered inflammatory response, oxidative 
stress, and tissue remodeling. Several key players that this group has identified in liver injury 
also appear to play important roles in the alcoholic lung. For example, LPS enhances injury due 
to ethanol in both organs (45). Additionally, fibrin mediates pro-inflammatory effects in lung (46). 
These observations further support the possibility of mechanistic overlap of alcohol-induced injury 
in these two organs. Therefore, it would be pertinent to determine if 133 containing integrins may 
mediate inflammation downstream of tissue remodeling in the lung. The role of integrins in 
enhanced susceptibility to pulmonary injury due to alcohol could be studied in a chronic alcohol 2-
hit model of organ injury using whole mouse knockouts of the 133 integrin subunit. 
32 
REFERENCES 
(1) Nelson S, Kolls JK. Alcohol, host defence and society. Nature Rev 
Immunol 2002 Mar;2(3):205-209. 
(2) Beier JI, Luyendyk JP, Guo L, von Montfort C, Staunton DE, Arteel GE. 
Fibrin accumulation plays a critical role in the sensitization to 
lipopolysaccharide-induced liver injury caused by ethanol in mice. 
Hepatology 2009 Jan 23;49(5): 1545-1553. 
(3) Qi J, Goralnick S, Kreutzer DL. Fibrin Regulation of Interleukin-8 Gene 
Expression in Human Vascular Endothelial Cells. Blood 1997;90:3595-
3602. 
(4) Loike JD, el Khoury J, Cao L, Richards CP, Rascoff H, Mandeville JT, et 
al. Fibrin regulates neutrophil migration in response to interleukin 8, 
leukotriene B4, tumor necrosis factor, and formyl-methionyl-Ieucyl-
phenylalanine. J Exp Med 1995 May 1;181(5):1763-1772. 
(5) Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM. Recognition of distinct 
adhesive sites on fibrinogen by related integrins on platelets and 
endothelial cells. Cell 1989 Sep 8;58(5):945-953. 
(6) Hynes RO. Integrins: versatility, modulation, and signaling in cell 
adhesion. Cell 1992 Apr 3;69(1):11-25. 
(7) Hapke S. Ovarian Cancer Cell Proliferation and Motility Is Induced by 
Engagement of Integrin avb3Nitronectin Interaction. 2005. 
(8) Nam J. FAS1 domain protein inhibits VEGF165-induced angiogenesis by 
targeting the interaction between VEGFR2 and avb3 integrin. 2012 Aug. 
(9) DiMaio T, Gutierrex K, Lagunoff M. Latent KSHV infection of endothelial 
cells induces integrin beta3 to activate angiogenic phenotypes. Pathogens 
2011 ;7(12):e1 002424. 
(10) Luzina I. Regulation of pulmonary inflammation and fibrosis through 
expression of integrins aiphaVbeta3 and alphaV beta5 on pulmonary T 
lymphocytes. 2009. 
(11) Giancotti FG, Ruoslahti E. Integrin Signalling. American Association for 
the Advancement of Science 1999;285:1028-1032. 
33 
(12) Barberis L, Wary KK, Fiucci G, Liu F, Hirsch E, Brancaccio M, et al. 
Distinct Roles of the Adaptor Protein Shc and Focal Adhesion Kinase in 
Integrin Signaling to ERK. J Bioi Chem 2000;275(47):36532-36540. 
(13) McDonald P. Integrin-linked kinase -- essential roles in physiology and 
cancer biology. 2008 Oct. 
(14) Lawson C. Integrin adhesions: Who's on first? What's on second? 2012. 
(15) Xie P, Kondeti V, Lin S, Haruna Y, Pararia K, Kanwar Y. Role of ECM 
Renal TINag in Cell Surivival Utilizing Integrin avb3/FAKlPI3K1AKT 
Signaling Pathway. Journal of Biological Chemistry 2011 ;286(39):34131-
34146. 
(16) Vanderslice P, Woodside DG. Integrin antagonists as therapeutics for 
inflammatory diseases. Expert Opin Investig Drugs 2006;15(10):1235-
1255. 
(17) Cai W, Chen X. Anti-angiogenic cancer therapy based on integrin 
alphavbeta3 antagonism. Anticancer Agents in Medicinal Chemistry 
2006;6(5):407 -428. 
(18) Zhou HF, Chan HW, Wickline SA, Lanza GM, Pham CT. Alphavbeta3-
targeted nanotherapy suppresses inflammatory arthritis in mice. FASEB J 
2009 Sep;23(9):2978-2985. 
(19) Carloni V, Romanelli RG, Pinzani M, Laffi G, Gentilini P. Expression and 
function of integrin receptors for collagen and laminin in cultured human 
hepatic stellate cells. Gastroenterology 1996 Apr;110(4):1127-1136. 
(20) Okada Y, Copeland BR, Hamann GF, Koziol JA, Cheresh DA, del Zoppo 
GJ. Integrin alphavbeta3 is expressed in selected microvessels after focal 
cerebral ischemia. Am J Pathol1996 Jul;149(1):37-44. 
(21) Hsu C-C, Chuang W-J, Chang C-H, Tseng Y-L, Peng H-C, Huang T-F. 
Improvements in endotoxemia syndromes using a disintegrin, 
rhodostomin, through integrin avb3-dependent pathway. International Society on 
Thrombosis and Haemostasis 2011 ;9:593-602. 
(22) Beier JI, Guo L, von Montfort C, Kaiser JP, Joshi-Barve S, Arteel GE. New 
role of resistin in lipopolysaccharide-induced liver damage in mice. J 
Pharmacol Exp Ther 2008 Mar 13;325(3):801-808. 
(23) Bergheim I, Guo L, Davis MA, Lambert JC, Beier JI, Duveau I, et al. 
Metformin prevents alcohol-induced liver injury in the mouse: Critical role 
of plasminogen activator inhibitor-1. Gastroenterology 2006 
Jun; 130(7):2099-2112. 
34 
(24) Guo L, Richardson KS, Tucker LM, Doll MA, Hein OW, Arteel GE. Role of 
the renin-angiotensin system in hepatic ischemia reperfusion injury in rats. 
Hepatology 2004 Sep;40(3):583-589. 
(25) Tan M, Schmidt RH, Beier JI, Watson WH, Zhong H, States JC, et al. 
Chronic subhepatotoxic exposure to arsenic enhances hepatic injury 
caused by high fat diet in mice. Toxicol Appl Pharmacol 2011 Dec 
15;257(3):356-364. 
(26) Privratsky JR, Newman OK, Newman JP. PECAM-1: Conflicts of Interest 
in Inflammation. Life Sciences 2012 JuI17;87(3):69-82. 
(27) Oktay M, Wary KK, Dans M, Birge RB, Giancotti FG. Integrin-mediated 
Activatin 0 fFocal Adhesion Kinase is Required for Signaling to Jun NH2-
terminal Kinase and Progression through the G1 Phase of the Cell Cycle. 
Journal of Cell Biology 1999;145(7):1461-1469. 
(28) Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 
1998 Apr;114(4):842-845. 
(29) Bode CH, Kugler V, Bode JCH. Endotoxemia in patients with alcoholic and 
non-alcoholic cirrhosis and in subjects with no evidence of chronic liver 
disease following acute alcohol excess. J Hepatol 1987;4:8-14. 
(30) Enomoto N, Ikejima K, Bradford BU, Rivera CA, Kono H, Goto M, et al. 
Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J 
Gastroenterol Hepatol 2000 Mar;15 Suppl:D20-D25. 
(31) Enomoto N, Ikejima K, Bradford BU, Rivera CA, Kono H, Brenner DA, et 
al. Alcohol causes both tolerance and sensitization of rat Kupffer cells via 
mechanisms dependent on endotoxin. Gastroenterology 1998 Jul 
24; 115(2):443-451. 
(32) Muller W, Weigl S, Deng X, Philips D. PECAM-1 is required for 
transendothelial migration of leukocytes. J Exp Med 1993; 178(2):449-460. 
(33) Piali L, Hammel P, Uherek C, Bachmann F, Gisler R, Dunon 0, et al. 
CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion 
of leukocytes to endothelium. Journal of Cell Biology 1995; 130(2):451-
460. 
(34) Vaporciyan A, DeLisser H, Van H, Mendiguren I, Thom S, Jones S, et al. 
Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil 
recruitment in vivo. Science 1993;262(5139):1580-1582. 
(35) Maas M, Stapleton M, Bergom C, Mattson 0, Newman 0, Newman P. 
Endothelial cell PECAM-1 confers protection against endotoxic shock. Am 
J Physiol Heart Circ PhysioI2005;288(1):159-164. 
35 
(36) Carrithers M, Tandon S, Canosa S, Michaud M, Graesser D, Madri J. 
Enhanced Susceptibility to Endotoxic Shock and Impaired STAT3 
Signaling in CD31-Deficient Mice. Am J PathoI2005;155(1):185-196. 
(37) Muller W, Ratti C, McDonnell S, Cohn Z. A human endothelial cell-
restricted externally disposed plasmalemmal protein enriched in 
intercellular junctions. J Exp Med 1989;170(2):399-414. 
(38) Ivaska J, Bosca L, Parker P. PKC-epsilon is a permissive link in integrin-
dependent IFN-gamma signaling that facilitates JAK phosphorylation of 
STAT1. Nature Cell Bioi 2003;5:363-369. 
(39) Izuta S, Ueki K, Ueno M, Nishina K, Shiozawa S, Maekawa N. T-5224, a 
selective inhibitor of c-Fos/activator protein-1, attenuates 
lipopolysaccharide-induced Ivier injury in mice. Biotechnol Lett 2012. 
(40) Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics 
prevent liver injury in rats following long-term exposure to ethanol. 
Gastroenterology 1995; 1 08:218-224. 
(41) Enomoto N, Ikejima K, Yamashina S, Enomoto A, Nishiura T, Nishimura 
T, et al. Kupffer cell-derived prostaglandin E(2) is involved in alcohol-
induced fat accumulation in rat liver. Am J Physiol Gastrointest Liver 
Physiol2000 Jul;279(1):G100-G106. 
(42) limuro Y, Ikejima K, Rose ML, Bradford BU, Thurman RG. Nimodipine, a 
dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis 
caused by chronic intragastric ethanol exposure in the rat. Hepatology 
1996 Aug;24(2):391-397. 
(43) Moss M, Bucher B, Moore FA, Moore EE, Parsons PE. The role of chronic 
alcohol abuse in the development of acute respiratory distress syndrome 
in adults. JAMA 1996 Jan 3;275(1):50-54. 
(44) Moss M, Parsons PE, Steinberg KP, Hudson LD, Guidot DM, Burnham 
EL, et al. Chronic alcohol abuse is associated with an increased incidence 
of acute respiratory distress syndrome and severity of multiple organ 
dysfunction in patients with septic shock. Crit Care Med 
2003;2003/03/11 :869-877. 
(45) Holguin F, Moss I, Brown LA, Guidot DM. Chronic ethanol ingestion 
impairs alveolar type II cell glutathione homeostasis and function and 
predisposes to endotoxin-mediated acute edematous lung injury in rats. J 
Clin Invest 1998 Feb 15;101(4):761-768. 
(46) Idell S. Endothelium and disordered fibrin turnover in the injured lung: 



























Platelet-endothelial cell adhesion molecule (PECAM) 
Extracellular signal-related kinases 1/2 
Ethanol 
Focal adhesion kinase 
Glyceraldheyde 3-phosphate dehydrogenase 
Hematoxylin & eosin 
Hyaluronic acid 





c-Jun N-terminal kinase 
Lipopolysaccharide 









Plasminogen activator inhibitor-1 
Sinusoidal endothelial cell 
Suppressor of cytokine signaling-1 
Signal transducers and activators of transcription 3 





Veronica L. Massey 
University of Louisville School of Medicine 
Department of Pharmacology and Toxicology 



















Lab assistant, Cincinnati Children's Hospital , Department of 
Developmental Biology 
Undergraduate researcher, University of Louisville, Department of 
Pharmacology-Toxicology 
Graduate Research Fellowship, Integrated Programs in 
Biomedical Sciences 
Xavier University Academic Scholarship 
Dean's List, Xavier University 
Vice President, Pharmacology-Toxicology Graduate Student 
Organization 
Student Representative, Student Affairs Committee 
Student Representative, VDR Search Committee 
Class Representative, University of Louisville 




Ohio Valley Chapter of the Society of Toxicology 




1. Massey VL and Arteel GE (2012). Acute alcohol-induced liver injury. Frontiers in 
Physiology. 3 (193) 1-8 
Abstracts - Regional 
1. Massey VL, Poole LG, Schmidt RH, Arteel GE (2012) Integrin 133-1- mice are 
protected against enhanced alcohol-induced liver injury. Research!Louisvilie 
Louisville, KY 
2. Massey VL, Beier JI, Schmidt RH, Zhong H, Arteel GE (2011) Ethanol 
sensitization to LPS-induced liver injury: protection by the integrin inhibitor, 
cycloRGDN. OVSOT Dayton, Ohio 
3. Massey VL, Beier JI, Schmidt RH, Zhong H, Arteel GE (2011) Integrin avf33 
mediates ethanol-enhanced liver damage caused by LPS. Research!Louisvilie 
Louisville, KY 
Abstracts - National/International 
1. Massey VL, Beier JI, Schmidt RH, Zhong H, Arteel GE (2011) Integrin inhibitor 
Cyclo-RGDN blunts enhanced LPS-induced liver injury caused by ethanol in 
mice. Hepatology 54(S1):970A 
2. Tan M, Massey VL, Ding X, Zhong H, States JC, and Arteel GE (2010) Arsenic 
pre-exposure delays cell cycle entry and progression in mouse liver after partial 
hepatectomy. Hepatology 52:462A 
PRESENTATIONS 
1. Research Seminar, 11/12, Parallel and interdependent mechanism of alcohol-
induced organ injury in the liver and lung. University of Louisville Alcohol 
Research Center, Louisville, KY 
2. Poster Presentation, 10/12, Integrin 133-1- mice are protected against enhanced 
alcohol-induced liver injury. Research!Louisvilie Louisville, KY 
3. Poster Presentation, 11/11, Integrin inhibitor Cyclo-RGDN blunts enhanced LPS-
induced liver injury caused by ethanol in mice. American Association for the 
Study of Liver Disease, San Francisco, CA. 
4. Poster Presentation, 10/11, Integrin aVf33 mediates ethanol-enhanced liver 
damage caused by LPS. Research!Louisville, Louisville, KY. 
5. Poster Presentation, 10/11, Ethanol sensitization to LPS-induced liver injury: 
protection by the integrin inhibitor, cycloRGDN. Ohio Valley Society of 
Toxicology Regional Meeting, Dayton, OH. 
6. Research Seminar, 03/11, Integrin inhibitor Cyclo-RGDN blunts enhanced LPS-
induced liver injury caused by ethanol in mice. University of Louisville, Seminar in 
Pharmacology and Toxicology, Louisville, KY. 
40 
